The Pep Edit Newsletter

Cheat sheet

Status: Not FDA-approved Reviewed

KPV

A fragment of alpha-MSH that comes up constantly in inflammation and skin conversations. Here is what the research shows, and what it does not.

The evidence rail

How to read this
  1. Mechanistic: reached
  2. Cell research: reached
  3. Animal research: reached
  4. Human observational: not reached
  5. Human clinical trial: not reached
  6. Established clinical use: not reached
Evidence
Animal researchRung 3 of 6. Studied in mice, rats, or other animals. Most peptide headlines live here.
Status
Not FDA-approvedNot approved for use as a drug. Often sold as a research chemical.

Why people are talking about it

It is a small piece of alpha-MSH, a hormone the body already uses to calm inflammation, so it gets framed as a gentle, natural option. It has also been named in FDA compounding reviews, which put it in the news.

What has it been studied for?

  • Inflammation, including gut-adjacent questions
  • Skin, in lab samples of donated human skin
  • Immune signaling around melanocortin pathways

What we know

  • The name is in active conversation, including compounding news
  • No published studies in people yet. The research is in cells, mice, and lab skin samples

What we don’t

  • Whether early signals hold in larger, well-controlled trials
  • How to translate a study into a personal decision. That is a clinician's job, not ours

What is known about safety

  • The FDA says it has not identified any human exposure data for drug products containing KPV, by any route, and does not know whether it would cause harm in people
  • The published work is in cells, mice, and lab samples of human skin. Those designs are not built to find side effects, rare harms, or long-term effects
  • Products sold online as research chemicals are not checked for identity, purity, or sterility

Bottom line

Promising is not proven. Read the paper.

Education only. Not medical advice. Not a protocol.

Sources

  1. Cells and micePepT1-mediated tripeptide KPV uptake reduces intestinal inflammation (opens in a new tab)Dalmasso and colleagues, Gastroenterology, 2008
  2. MiceMelanocortin-derived tripeptide KPV has anti-inflammatory potential in murine models of inflammatory bowel disease (opens in a new tab)Kannengiesser and colleagues, Inflammatory Bowel Diseases, 2008
  3. Lab study on donated human skin, no volunteersTransdermal iontophoretic delivery of KPV across microporated human skin (opens in a new tab)Journal of Pharmaceutical Sciences, 2017
  4. Regulator statementCertain bulk drug substances for use in compounding that may present significant safety risks (opens in a new tab)US Food and Drug Administration, current as of April 2026

We link to the paper, the trial registry, or the regulator, never to a seller. A study type in the label tells you who or what was actually studied.

Spotted an error or a newer study? Tell the editors. Corrections are noted on the page. Our standards.

Keep reading

  • BPC-157

    Widely discussed for gut and recovery. The animal literature is large. Human clinical evidence is still thin.

    Evidence: Limited human data. Reached rung 4 of 6, Human observational, with limited data.Not FDA-approved
    Gut healthRecoveryInflammation
    Gut / Recovery

  • Larazotide

    One of the few names in this space with multiple human trials, studied around celiac and tight junctions.

    Evidence: Human clinical trials. Reached rung 5 of 6, Human clinical trial.Investigational
    Gut health
    Gut

  • ARA-290

    Studied in nerve pain and inflammation. Small placebo-controlled trials exist. Large ones do not.

    Evidence: Small controlled trials. Reached rung 5 of 6, Human clinical trial, with limited data.Not FDA-approved
    Nerve + painInflammation
    Nerve / Pain

Every new sheet, once a month.

One email a month. The study type named, every time.